Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Net Current Assets

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹5,918 Cr₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,918 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹5,918 Cr
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹5,918 Cr
13.42
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,548.2 Cr -2% 17.8% 43.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1.8% -1.6% 16.5% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr -1.2% 17.3% 38.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -2.3% -2% 33.6% Stock Analytics
CIPLA ₹114,715.0 Cr 0.2% 1.7% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.2% 3.6% -7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2%

17.8%

43.1%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses